These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8917702)
1. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Bain LJ; LeBlanc GA Toxicol Appl Pharmacol; 1996 Nov; 141(1):288-98. PubMed ID: 8917702 [TBL] [Abstract][Full Text] [Related]
2. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites. Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072 [TBL] [Abstract][Full Text] [Related]
3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity. Taub ME; Podila L; Ely D; Almeida I Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365 [TBL] [Abstract][Full Text] [Related]
4. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system. Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. Smith BJ; Doran AC; McLean S; Tingley FD; O'Neill BT; Kajiji SM J Pharmacol Exp Ther; 2001 Sep; 298(3):1252-9. PubMed ID: 11504828 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance induced by ouabain via the stimulation of MDR1 gene expression in human carcinomatous pulmonary cells. Brouillard F; Tondelier D; Edelman A; Baudouin-Legros M Cancer Res; 2001 Feb; 61(4):1693-8. PubMed ID: 11245485 [TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
10. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells. Ghetie MA; Ghetie V; Vitetta ES Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321 [TBL] [Abstract][Full Text] [Related]
11. Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Molnár J; Kars MD; Gündüz U; Engi H; Schumacher U; Van Damme EJ; Peumans WJ; Makovitzky J; Gyémánt N; Molnár P Acta Histochem; 2009; 111(4):329-33. PubMed ID: 19124148 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. Dey S; Gunda S; Mitra AK J Pharmacol Exp Ther; 2004 Oct; 311(1):246-55. PubMed ID: 15175422 [TBL] [Abstract][Full Text] [Related]
13. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay. Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789 [TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444 [TBL] [Abstract][Full Text] [Related]
15. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein. Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ J Pharmacol Exp Ther; 2004 Sep; 310(3):1199-207. PubMed ID: 15100388 [TBL] [Abstract][Full Text] [Related]
17. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
18. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326 [TBL] [Abstract][Full Text] [Related]
19. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells. Gopinath VS; Thimmaiah P; Thimmaiah KN Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543 [TBL] [Abstract][Full Text] [Related]
20. Interaction of pyridostigmine bromide and N,N-diethyl-m-toluamide alone and in combination with P-glycoprotein expressed in Escherichia coli leaky mutant. El-Masry EM; Abou-Donia MB J Toxicol Environ Health A; 2006 May; 69(10):919-33. PubMed ID: 16728371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]